Unknown

Dataset Information

0

Effect of renin angiotensin system blockade on pentraxin 3 levels in type-2 diabetic patients with proteinuria.


ABSTRACT: Long pentraxin 3 (PTX3) is a multimeric inflammatory mediator. Increased serum PTX3 levels have been reported among end-stage renal disease patients. Moreover, PTX3 has been suggested to represent a novel mortality risk factor, and elevated PTX3 levels have been shown to accompany increased albuminuria among patients with chronic kidney disease (CKD).We analyzed data of 49 persons with stage 1 diabetic CKD and 32 healthy subjects in a prospective controlled trial. Endothelial dysfunction was determined by flow-mediated dilation (FMD). Serum PTX3, high-sensitivity C-reactive protein (hs-CRP) levels, and FMD were studied in baseline and after 12 wk of ramipril therapy. Stepwise multivariate regression analysis evaluated the association of FMD with clinical and serologic parameters.Serum PTX3, hsCRP, and albumin levels and proteinuria were significantly decreased, and FMD levels were significantly increased, after ramipril treatment. FMD was negatively correlated with serum PTX3, 24-h proteinuria, and hsCRP levels and positively correlated to serum albumin both at baseline and after the 12-wk treatment period. Multivariate regression analysis revealed that PTX3 levels were independently related to FMD both before and after ramipril treatment.Our study shows that serum PTX3 levels are associated with endothelial dysfunction in patients with stage 1 diabetic CKD, independent of CRP. In addition, short-term ACE-inhibitor treatment significantly improves FMD and normalizes PTX3, hsCRP, and urinary protein excretion. (NCT: The study was registered in clinicaltrials.gov as NCT00674596.).

SUBMITTER: Yilmaz MI 

PROVIDER: S-EPMC2653664 | biostudies-literature | 2009 Mar

REPOSITORIES: biostudies-literature

altmetric image

Publications

Effect of renin angiotensin system blockade on pentraxin 3 levels in type-2 diabetic patients with proteinuria.

Yilmaz Mahmut Ilker MI   Axelsson Jonas J   Sonmez Alper A   Carrero Juan Jesus JJ   Saglam Mutlu M   Eyileten Tayfun T   Caglar Kayser K   Kirkpantur Alper A   Celik Turgay T   Oguz Yusuf Y   Vural Abdulgaffar A   Yenicesu Mujdat M   Lindholm Bengt B   Stenvinkel Peter P  

Clinical journal of the American Society of Nephrology : CJASN 20090211 3


<h4>Background and objectives</h4>Long pentraxin 3 (PTX3) is a multimeric inflammatory mediator. Increased serum PTX3 levels have been reported among end-stage renal disease patients. Moreover, PTX3 has been suggested to represent a novel mortality risk factor, and elevated PTX3 levels have been shown to accompany increased albuminuria among patients with chronic kidney disease (CKD).<h4>Design, setting, participants, & measurements</h4>We analyzed data of 49 persons with stage 1 diabetic CKD an  ...[more]

Similar Datasets

| S-EPMC6962440 | biostudies-literature
| S-EPMC7666106 | biostudies-literature
| S-EPMC3817897 | biostudies-literature
| S-EPMC3567880 | biostudies-other
| S-EPMC3268972 | biostudies-literature
| S-EPMC7929063 | biostudies-literature
| S-EPMC3817905 | biostudies-literature
| S-EPMC9712183 | biostudies-literature
| S-EPMC8947214 | biostudies-literature
| S-EPMC2396930 | biostudies-literature